Browse Items (30 total)
- Tags: Community-acquired pneumonia
Treatment of community-acquired pneumonia in immunocompromised adults: A consensus statement regarding initial strategies
Tags: 2020, Aliberti S, Anzueto A, Arancibia F, Arnold F, Azoulay E, Blasi F, Bordon J, Burdette S, Cao B, Cavallazzi R, Chalmers J, Charles P, Chastre J, Chest, Claessens Y-E, Community-acquired pneumonia, Crothers KA, Dean N, Dela CC, Department of Internal Medicine, Duval X, Evans SE, Fartoukh M, Feldman C, File T, Froes F, Furmanek S, Gnoni M, Hage CA, immunocompromised, journalArticle, Lopardo G, Luna C, Maruyama T, Menendez R, Metersky M, Mildvan D, Mortensen E, Musher DM, NEOMED College of Medicine, Niederman MS, October 2020 List, Pletz M, Pneumonia, Ramirez JA, Rello J, Restrepo MI, Shindo Y, Summa Health System Akron City Hospital, Torres A, Waterer G, Webb B, Welte T, Witzenrath M, Wunderink R
Gemifloxacin Once Daily For 7 Days Compared To Amoxicillin/clavulanic Acid Thrice Daily For 10 Days For The Treatment Of Community-acquired Pneumonia Of Suspected Pneumococcal Origin
Tags: 2004, adults, Antimicrobial resistance, Cardiovascular System & Cardiology, Community-acquired pneumonia, Feldman C, File T, Fluoroquinolone, Gemifloxacin, guidelines, Journal Article or Conference Abstract Publication, Leophonte P, Levofloxacin, Management, pneumococcal pneumonia, Respiratory Medicine, Respiratory System, streptococcus-pneumoniae, surveillance, therapy, trovafloxacin, united-states
Antimicrobial Treatment Of Lower Respiratory Tract Infections In The Hospital Setting
Tags: 2005, 5-day levofloxacin, acute exacerbations, American Journal of Medicine, antibiotic-therapy, Antibiotics, chronic-bronchitis, Community-acquired pneumonia, community-associated pneumonia, drug-interaction, General & Internal Medicine, Grossman R F, healthcare-associated, hospital-acquired, Journal Article or Conference Abstract Publication, open-label, quinolones, randomized-trial, Rotschafer J C, streptococcus-pneumoniae, Tan J S, ventilator-associated, ventilator-associated pneumonia
The Clinical Relevance Of Penicillin-resistant Streptococcus Pneumoniae: A New Perspective
Tags: 2006, antibiotic-resistance, bacteremia, Boex J R, Clinical Infectious Diseases, Community-acquired pneumonia, Department of Family & Community Medicine, Epidemiology, File T M, Immunology, Infectious Diseases, metaanalysis, Microbiology, Molecular, Mortality, NEOMED College of Medicine, outcomes, pneumococcal pneumonia, susceptibility, Tan J S, united-states
Clinical Implications Of 750mg, 5-day Levofloxacin For The Treatment Of Community Acquired Pneumonia
Tags: 2004, adults, antimicrobial therapy, Community-acquired pneumonia, controlled-trial, critical pathway, Current medical research and opinion, early switch, File T M, General & Internal Medicine, guidelines, Khashab M M, Levofloxacin, Management, Milkovich G, oral antibiotics, Research & Experimental Medicine, resolution, short-course, symptom, Tennenberg A M, Xiang J X, Zadeikis N
Rational Use Of Antibiotics To Treat Respiratory Tract Infections
Tags: 2002, acute bronchitis, acute otitis-media, American Journal of Managed Care, Antimicrobial, Community-acquired pneumonia, File T M, General & Internal Medicine, group, Hadley J A, Health Care Sciences & Services, judicious use, obstructive, placebo-controlled trial, pulmonary-disease, resistance, resistant streptococcus-pneumoniae, therapeutic working, united-states
New Insights In The Treatment By Levofloxacin
Tags: 2004, adults, amoxicillin-clavulanate, Chemotherapy, Community-acquired pneumonia, File T M, Fluoroquinolones, high-dose therapy, hong-kong, Levofloxacin, multicenter, oncology, open-label, Pharmacology & Pharmacy, resistance, respiratory infection, Safety, streptococcus-pneumoniae, surveillance, trial
Fluoroquinolones And Respiratory Tract Infections: Do They Work?
Tags: 1997, acute, antibacterial activity, antibiotic-therapy, chronic-bronchitis, Community-acquired pneumonia, exacerbations, File T M, Hospitalization, Immunology, in-vitro, Infectious Diseases, Infectious Diseases in Clinical Practice, obstructive pulmonary-disease, oral ciprofloxacin, requiring, streptococcus-pneumoniae
Duration And Cessation Of Antimicrobial Treatment
Tags: 2012, acinetobacter-baumannii, antibiotic-therapy, Antimicrobial resistance, Case Studies, catheter-related bloodstream, clinical-practice guidelines, Community-acquired pneumonia, complicated intra-abdominal, course, File T M, General & Internal Medicine, healthcare-associated pneumonia, hospital-acquired pneumonia, Infection, infectious-diseases-society, intensive-care units, Journal of hospital medicine, pseudomonas-aeruginosa, resistant, short-course therapy, staphylococcus-aureus bacteremia, streptococcus-pneumoniae, ventilator-acquired pneumonia, ventilator-associated pneumonia
Clinical and public health implications of macrolide-resistant Streptococcus pneumoniae
Tags: 2002, Community-acquired pneumonia, Consensus Working Grp, decreased susceptibility, erythromycin resistance, group-a, haemophilus-influenzae, in-vitro, Infectious Diseases, initial antimicrobial therapy, Journal Article or Conference Abstract Publication, Journal of Chemotherapy, macrolide resistance, macrolides, Moellering R C, moraxella-catarrhalis, oncology, otitis-media, Pathology, Pharmacology & Pharmacy, pneumococcal resistance, pneumoniae, respiratory, S., streptococci, tract infections, Treatment Failure, united-states
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
Tags: 2012, a h1n1 virus, Antibacterial agents, Antiviral agents, asian influenza, Babinchak T, bacteremic pneumococcal, Bacterial, Community-acquired pneumonia, File T M, hong-kong influenza, Human, Infectious Diseases, Influenza, Influenza A, International Journal of Infectious Diseases, Journal Article or Conference Abstract Publication, Lode H, Masterton R G, Metersky M L, pandemic, Pneumonia, pregnant-women, randomized controlled-trial, respiratory-tract, streptococcus-pneumoniae, virus
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults
Tags: 2012, acute maxillary sinusitis, acute otitis-media, Benninger M S, Brook I, Brozek J L, Chow A W, Clinical Infectious Diseases, Community-acquired pneumonia, controlled-trial, diagnosed acute, File T M, general-practice population, Goldstein E J C, Hicks L A, Immunology, Infections, Infectious Diseases, Journal Article or Conference Abstract Publication, Microbiology, Pankey G A, placebo-controlled trial, pneumococcal conjugate vaccine, randomized, resistant, respiratory-tract, Rhinosinusitis, Seleznick M, streptococcus-pneumoniae, Volturo G, Wald E R
Community-Acquired Pneumonia in Older Adults
Respiratory infections unique to Asia
Tags: 2008, adult patients, avian influenza, Community-acquired pneumonia, eosinophilia, File T M, h5n1, hong-kong, Influenza, Journal Article, Management, negative pulmonary tuberculosis, parasite, Pneumonia, randomized controlled-trial, respiratory syndrome, Respiratory System, Respirology, scrub typhus, severe acute, syndrome sars, tropical infection, Tsang K W
Legionnaires disease with bacteremic coinfection
Risk factors for domestic acquisition of Legionnaires disease
Tags: 1996, Anderson C J, Archives of internal medicine, Baird I, Barbaree J, Benson R F, Bollin G E, Breiman R F, Community-acquired pneumonia, cooling-tower, Emerick J, evaporative condenser, Farkas S A, Fields B, File T M, Francis S J, Gardner W G, General & Internal Medicine, Gianakopoulos G, Hackman B H, Herbert M, hot, Journal Article, legionella-pneumophila serogroup-1, Lipman H B, monoclonal-antibody, Morrill W, Moyenuddin M, Myers J P, outbreak, Parsons J, Plouffe J F, potable water, Pruckler J, Salstrom S J, Signs D J, StJohn A, Straus W L, Tan J S, tap water, Thomson R B, united-states, water-systems
A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria
Tags: 2005, acute exacerbations, American Journal of Medicine, Amin A, antibiotic therapy resistance, Antibiotics, antimicrobials, Brunton S A, Carat, cefuroxime axetil, chronic bronchitis, clarithromycin, Community-acquired pneumonia, double-blind, efficacy, File T M, General & Internal Medicine, Journal Article, Milkovich G, pharmacodynamics, respiratory-tract infections, Rodvold K A, Sahm D F, Slama T G, Streptococcus pneumoniae, Varon J, Weiland D
Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >= 50 Years With Community-Acquired Pneumonia
Tags: 13-valent pneumococcal, 2013, Alexander R, care-associated pneumonia, cohort, Community-acquired pneumonia, conjugate vaccine, Disease, efficacy, Epidemiology, File T M, Graepel J, Gray S, healthcare-associated pneumonia, Immunization, Immunology, Infectious Diseases, Journal Article, Journal of Infectious Diseases, McGovern P C, Microbiology, older-adults, Paradiso P, pneumococcal serotypes, polysaccharide vaccine, Population, Pride M W, Purdy J, serotype distribution, Sherwin R L, Streptococcus pneumoniae, united-states, urinary antigen detection assay
Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem
Tags: 2004, acute exacerbation, acute otitis media, airway inflammation, Antimicrobial resistance, chronic bronchitis, chronic obstructive, Community-acquired pneumonia, Current medical research and opinion, Disease, empiric therapy, File T M, General & Internal Medicine, haemophilus-influenzae, Journal Article, moraxella-catarrhalis, obstructive-pulmonary-disease, pneumococcal, Pneumonia, pulmonary, Research & Experimental Medicine, resistance, resistant streptococcus-pneumoniae, Sethi S, surveillance program
Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremia
Tags: 2010, adults, assay binax, bacteremia, Bonilla H, Community-acquired pneumonia, Diagnosis, Diagnostic Microbiology and Infectious Disease, etiologic diagnosis, File T M, Infections, Infectious Diseases, Journal Article, Management, Microbiology, Paxos M, pneumococcal pneumonia, rapid diagnosis, Selickman J, Seltzer R, severity, sputum culture, Streptococcus pneumoniae, Urinary antigen
How long should we treat community-acquired pneumonia?
Tags: 2007, antibacterial response, antibiotic-therapy, antimicrobial therapy, azithromycin, clinical-efficacy, Community-acquired pneumonia, Current opinion in infectious diseases, double-blind, duration of therapy, File T M, Infectious Diseases, Journal Article, Practice Guidelines, respiratory-tract infections, Scalera N M, short-duration therapy, Streptococcus pneumoniae
Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US Adults
Tags: 2009, changing epidemiology, Community-acquired, Community-acquired pneumonia, conjugate vaccine, Farley M M, File T M, General & Internal Medicine, H1N1 influenza, Hall W J, Hopkins R, invasive pneumococcal disease, Journal Article, Levine O S, Meningitis, Nichol K L, Nuorti P, older-adults, pneumococcal disease, Pneumonia, Postgraduate medicine, PPSV23, Rehm S J, Schaffner W, united-states, Zimmerman R K
Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA
Tags: 2013, blood-stream infections, CA-MRSA, Community-acquired pneumonia, Community-associated methicillin-resistant Staphylococcus aureus, Community-associated MRSA, Disease, Epidemiology, File T M, Ford K D, Grp Impact-Hap Study, Haque N Z, Infectious Diseases, intensive care, International Journal of Infectious Diseases, Jabrocki B, Journal Article, Molecular, Mortality, MRSA, mrsa strains, Nosocomial pneumonia, outcomes, panton-valentine leukocidin, Pasquale T R, Peyrani P, Ramirez J A, risk-factors, Salstrom S J, Scerpella E G, ventilator-associated pneumonia, Wiemken T L, Zervos M J
Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia
Tags: 2007, antibiotic resistance, azithromycin, bacteremia, Camargo C A, clarithromycin, Community-acquired pneumonia, Emergency Medicine, erythromycin, File T M, Harper M B, Investigators E MNet, Journal Article, Journal of Emergency Medicine, Kelley M, macrolide resistance, Mortality, Neuman M I, Outpatients, penicillin, Streptococcus pneumoniae, streptococcus-pneumoniae bacteremia, surveillance, united-states
An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic
Tags: 2019, Chitra Surya, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, Communicable Diseases, community-acquired bacterial pneumonia, Community-acquired pneumonia, DENTAL discoloration, Department of Internal Medicine, File Thomas M, McGovern Paul C, NEOMED College of Medicine, omadacycline, Opal Steven, Patient Safety, Safety, September 2019 Update, skin and skin structure infections, Skin Diseases, TEETH abnormalities, tetracycline, THERAPEUTIC use, Tzanis Evan, van der Poll Tom
Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
Tags: 2017, 80 and over, Adult, Aged, Anti-Bacterial Agents/adverse effects/*therapeutic use, Atypical pathogen, Bacterial/*drug therapy, Ceftaroline fosamil, Ceftriaxone/adverse effects/*therapeutic use, Cephalosporins/adverse effects/*therapeutic use, Chlamydial Pneumonia, Chlamydophila pneumoniae, Clinical Trials, Combination/adverse effects/methods, Community-Acquired Infections/*drug therapy, Community-acquired pneumonia, Department of Internal Medicine, Double-Blind Method, Drug Therapy, Eckburg Paul B, Female, File Thomas M Jr, Friedland H David, Humans, International journal of antimicrobial agents, Legionella pneumophila, Llorens Lily, Macrolide, Macrolides/adverse effects/*therapeutic use, Male, Middle Aged, Mycoplasma, Mycoplasma pneumoniae, NEOMED College of Medicine, Phase III as Topic, Pneumonia, Randomized Controlled Trials as Topic, Talbot George H, Time Factors, Treatment Outcome